FDA’s ANDA Approvals(5月10日)
公開日時 2010/05/12 04:00
FDA's ANDA Approvals |
Applicant |
Active Ingredients |
Number |
Date Approved |
Dr. Reddy's |
Irinotecan HCl, 40 mg/2 mL (20 mg/mL) and 100 mg/5 mL (20 mg/mL) inj. |
78-953 |
4/15/2010 |
Teva |
Tamsulosin HCl, 0.4 mg caps |
77-630 |
4/27/2010 |
Sandoz |
Tamsulosin HCl, 0.4 mg caps. |
78-015 |
4/27/2010 |
Zydus |
Tamsulosin HCl, 0.4 mg caps. |
78-225 |
4/27/2010 |
Synthon |
Tamsulosin HCl, 0.4 mg caps. |
78-801 |
4/27/2010 |
Wockhardt |
Tamsulosin HCl, 0.4 mg caps. |
78-938 |
4/27/2010 |
Sandoz |
Vancomycin HCl, EQ 500 mg base/vial and EQ 1 gm base/vial inj. |
90-250 |
4/27/2010 |
Mylan |
Tamsulosin HCl, 0.4 mg caps. |
90-408 |
4/27/2010 |
Sigmapharm |
Protriptyline HCl, 5 mg and 10 mg tabs. |
90-462 |
5/3/2010 |
Mylan |
Bupropion HCl, 150 mg extended-release tabs. |
90-941 |
5/3/2010 |
(The Pink Sheet 5月10日号より) FDAと米国製薬企業の情報満載 “The Pink Sheet”はこちらから